OKYO Pharma Ltd
OKYO3.120USD
+0.020+0.65%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
3.120USD+3.120After-hours (ET)
112.38MMarket Cap
--P/E TTM
OKYO Pharma Ltd
3.120
+0.020+0.65%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025H1
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
FY2021H2
FY2021H1
FY2020H2
FY2020H1
FY2019H2
FY2019H1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
96.45%-241.34K
9.55%-4.33M
-133.95%-6.79M
-45.56%-4.79M
-33.42%-2.90M
-303.27%-3.29M
-407.64%-2.18M
-307.27%-816.28K
43.65%-428.71K
73.70%-200.43K
0.36%-760.74K
---762.18K
---763.50K
Net income from continuing operations
53.09%-4.10M
-13.03%-9.87M
-91.74%-8.73M
-105.57%-8.73M
-131.06%-4.56M
-102.54%-4.25M
-114.26%-1.97M
-4655.79%-2.10M
30.31%-920.14K
101.79%46.02K
-10.70%-1.32M
---2.57M
---1.19M
Operating gains losses
-42.58%1.19K
-8.20%2.23K
51.53%2.08K
56.28%2.43K
-88.50%1.37K
-79.30%1.55K
373.01%11.91K
65.42%7.50K
1408.38%2.52K
2615.57%4.54K
--167.00
--167.00
----
Other non-cash items
79.33%868.76K
339.31%4.05M
-6.55%484.45K
-19.31%921.49K
-16.13%518.40K
202.40%1.14M
17.55%618.10K
192.67%377.64K
-10.27%525.82K
-123.56%-407.53K
58.94%586.00K
--1.73M
--368.68K
Change in working capital
105.22%2.99M
-50.83%1.48M
28.54%1.46M
1693.35%3.01M
235.62%1.13M
-121.11%-189.09K
-2162.34%-834.78K
472.07%895.56K
-39.20%-36.90K
108.84%156.55K
-143.74%-26.51K
--74.96K
--60.60K
-Change in receivables
-151.52%-204.39K
264.95%206.41K
256.92%396.75K
107.88%56.56K
296.41%111.16K
-19442.39%-718.18K
-136.98%-56.59K
-98.40%3.71K
144.25%153.03K
374.32%232.61K
-2095.16%-345.80K
---84.79K
---15.75K
-Change in payables and accrued expense
119.46%2.54M
-13.81%1.87M
46.40%1.16M
333.54%2.17M
199.15%792.09K
-45.92%500.92K
-220.95%-798.91K
973.89%926.21K
-177.96%-248.92K
-166.34%-105.99K
318.19%319.30K
--159.75K
--76.35K
-Change in other current liabilities
185.87%86.92K
-170.08%-516.95K
-232.08%-101.22K
2517.94%737.68K
269.83%76.64K
181.77%28.18K
2306.82%20.72K
-215.15%-34.46K
---939.00
--29.93K
--0.00
----
----
Cash from non-recurring investing activities
Cash from operating activities
96.45%-241.34K
9.55%-4.33M
-133.95%-6.79M
-45.56%-4.79M
-33.42%-2.90M
-303.27%-3.29M
-407.64%-2.18M
-307.27%-816.28K
43.65%-428.71K
73.70%-200.43K
0.36%-760.74K
---762.18K
---763.50K
Investing cash flow
Net cash from continuing investing activities
----
-100.00%0.00
----
109.11%3.49K
--2.43K
-52.75%1.67K
-100.00%0.00
--3.53K
--1.50K
-100.00%0.00
--0.00
--1.01K
----
Capital expenditures
----
-100.00%0.00
----
109.11%3.49K
--2.43K
-52.75%1.67K
-100.00%0.00
--3.53K
--1.50K
-100.00%0.00
--0.00
--1.01K
----
Net cash flow from disposal of fixed assets
----
-100.00%0.00
----
109.11%3.49K
--2.43K
-52.75%1.67K
-100.00%0.00
--3.53K
--1.50K
-100.00%0.00
--0.00
--1.01K
----
Net cash flow from other investing activities
----
----
----
----
----
----
----
91.82%-8.54K
----
---104.34K
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
----
100.00%0.00
----
-109.11%-3.49K
---2.43K
86.17%-1.67K
100.00%0.00
88.43%-12.07K
---1.50K
-10190.14%-104.34K
--0.00
---1.01K
----
Financing cash flow
Cash flow from continuous financing activities
-86.20%551.81K
-61.70%3.00M
169.52%4.00M
600.71%7.84M
43.46%1.48M
1819.07%1.12M
-82.76%1.03M
-86.75%58.30K
1695.74%6.00M
--440.06K
--334.23K
----
----
Net cash flow from debt Issuance/repayment
--550.00K
----
----
18377.46%2.00M
100.00%0.00
-76.57%10.82K
-100.19%-10.82K
-24.20%46.19K
8950.52%5.82M
--60.94K
---65.77K
----
----
Net cash flow from common stock issuance/repurchase
-100.00%0.00
-43.59%3.00M
99.90%4.00M
--5.32M
--2.00M
--0.00
-100.00%0.00
-100.00%0.00
-54.66%181.35K
--379.13K
--400.00K
----
----
Proceeds from stock option exercised by employees
----
----
----
----
----
----
--0.00
--11.25K
----
--0.00
----
----
----
Proceeds from issuance of warrants
----
----
----
----
-100.00%0.00
--1.11M
--1.05M
----
----
----
----
----
----
Net cash flow from other financing activities
--1.81K
----
----
--516.90K
---516.90K
----
----
--858.00
----
----
----
----
----
Net cash from non-recurrent financing activities
Net cash from financing activities
-86.20%551.81K
-61.70%3.00M
169.52%4.00M
600.71%7.84M
43.46%1.48M
1819.07%1.12M
-82.76%1.03M
-86.75%58.30K
1695.74%6.00M
--440.06K
--334.23K
----
----
Net cash flow
Beginning cash balance
-79.56%826.85K
63.83%2.10M
96.81%4.05M
-77.75%1.28M
-58.82%2.06M
-0.25%5.75M
2528.01%4.99M
10443.51%5.76M
-60.52%189.94K
-95.61%54.65K
-76.04%481.15K
--1.24M
--2.01M
Current period cash flow changes
106.60%160.35K
-143.75%-1.33M
-70.75%-2.43M
239.98%3.04M
-24.53%-1.42M
-182.41%-2.17M
-120.49%-1.14M
-669.17%-770.05K
1406.38%5.57M
117.74%135.29K
44.17%-426.51K
---762.73K
---763.97K
Effect of exchange rate changes
-141.13%-150.12K
----
--364.96K
----
----
----
----
----
----
----
----
--465.00
---465.00
Ending cash balance
-38.97%987.20K
-82.34%763.35K
155.27%1.62M
20.99%4.32M
-83.54%633.63K
-28.42%3.57M
-33.18%3.85M
2528.01%4.99M
10443.51%5.76M
-60.52%189.94K
-95.61%54.65K
--481.15K
--1.24M
Free cash flow
----
9.61%-4.33M
----
-45.60%-4.80M
-33.53%-2.91M
-301.73%-3.29M
-405.87%-2.18M
-309.03%-819.81K
43.45%-430.20K
73.74%-200.43K
---760.74K
---763.19K
----
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
